INC Research company info

What does INC Research do?
InterCure (TASE:INCR), (TSX:INCR.U), (NASDAQ:INCR), operating under the brand Canndoc, is a leading Israeli medical cannabis producer. They hold a coveted GMP (Good Manufacturing Practices) certification, ensuring pharmaceutical-grade quality for their cannabis products. InterCure operates a vertically integrated business model, overseeing "seed-to-sale" processes. They boast a strong distribution network and international partnerships, solidifying their position as a major player in the rapidly growing global medical cannabis market outside North America.
INC Research company media
Company Snapshot

Is INC Research a public or private company?

key
Ownership
Public

How many people does INC Research employ?

people
Employees
270

What sector is INC Research in?

pie chart
Sector
Health Care

Where is the head office for INC Research?

location pin
Head Office
Herzliya, Israel

What year was INC Research founded?

founded flag
Year Founded
1994
What does INC Research specialise in?
/Clinical Research /Biopharmaceutical Services /Global Trials /Therapeutic Application /Drug Development /Data Solutions

What are the products and/or services of INC Research?

Overview of INC Research offerings
Production of Pharmaceutical-Grade Cannabis: InterCure cultivates and produces various cannabis strains following Good Manufacturing Practices (GMP) certification standards. This ensures their products meet strict quality and safety requirements for medical use.
Product Variety: InterCure offers a variety of medical cannabis products, including: Dried cannabis inflorescences (flowers) and Cannabis extracts mixed with oil.
Research and Development: InterCure might invest in research and development activities to improve cultivation techniques, explore new product formulations, and potentially develop novel cannabis-based medicines.
Distribution Network: They have established a robust distribution network to deliver their medical cannabis products to hospitals, pharmacies, research institutions, and potentially government-approved dispensaries.
International Partnerships: InterCure leverages strategic partnerships with companies in other countries to expand their market reach and potentially gain access to new technologies or cultivation methods. Their recent focus on Germany exemplifies this strategy.
Seed-to-Sale Model: InterCure might operate a vertically integrated business model, overseeing the entire process from cultivating cannabis seeds to selling finished products to licensed distributors and patients.

Who is in the executive team of INC Research?

INC Research leadership team
  • Mr. Alexander  Rabinovich
    Mr. Alexander Rabinovich
    CEO & Director
  • Mr. Amos  Cohen
    Mr. Amos Cohen
    Chief Financial Officer
  • Einat  Zehavi
    Einat Zehavi
    Vice President of Sales
  • Mr. Omri  Batzir
    Mr. Omri Batzir
    Corporate Controller